Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

被引:13
作者
Preisinger, C. [1 ,2 ,3 ]
Schwarz, J. P. [4 ]
Bleijerveld, O. B. [1 ,2 ,3 ]
Corradini, E. [1 ,2 ,3 ]
Mueller, P. J. [5 ]
Anderson, K. I. [4 ]
Kolch, W. [6 ]
Scholten, A. [1 ,2 ,3 ]
Heck, A. J. R. [1 ,2 ,3 ,7 ]
机构
[1] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, Utrecht, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
[3] Netherlands Prote Ctr, Utrecht, Netherlands
[4] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[5] Rhein Westfal TH Aachen, Dept Biochem, Aachen, Germany
[6] Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland
[7] Ctr Biomed Genet, Utrecht, Netherlands
关键词
ADAPTER PROTEIN; KINASE; DOMAIN;
D O I
10.1038/leu.2012.243
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:743 / 746
页数:4
相关论文
共 15 条
[1]   A curated compendium of phosphorylation motifs [J].
Amanchy, Ramars ;
Periaswamy, Balamurugan ;
Mathivanan, Suresh ;
Reddy, Raghunath ;
Tattikota, Sudhir Gopal ;
Pandey, Akhilesh .
NATURE BIOTECHNOLOGY, 2007, 25 (03) :285-286
[2]   In-depth Qualitative and Quantitative Profiling of Tyrosine Phosphorylation Using a Combination of Phosphopeptide Immunoaffinity Purification and Stable Isotope Dimethyl Labeling [J].
Boersema, Paul J. ;
Foong, Leong Yan ;
Ding, Vanessa M. Y. ;
Lemeer, Simone ;
van Breukelen, Bas ;
Philp, Robin ;
Boekhorst, Jos ;
Snel, Berend ;
den Hertog, Jeroen ;
Choo, Andre B. H. ;
Heck, Albert J. R. .
MOLECULAR & CELLULAR PROTEOMICS, 2010, 9 (01) :84-99
[3]   Charting the molecular network of the drug target Bcr-Abl [J].
Brehme, Marc ;
Hantschel, Oliver ;
Colinge, Jacques ;
Kaupe, Ines ;
Planyavsky, Melanie ;
Koecher, Thomas ;
Mechtler, Karl ;
Bennett, Keiryn L. ;
Superti-Furga, Giulio .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (18) :7414-7419
[4]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[5]   A common phosphotyrosine signature for the Bcr-Abl kinase [J].
Goss, Valerie L. ;
Lee, Kimberly A. ;
Moritz, Albrecht ;
Nardone, Julie ;
Spek, Erik J. ;
MacNeill, Joan ;
Rush, John ;
Comb, Michael J. ;
Polakiewicz, Roberto D. .
BLOOD, 2006, 107 (12) :4888-4897
[6]   Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML [J].
Helgason, G. Vignir ;
Karvela, Maria ;
Holyoake, Tessa L. .
BLOOD, 2011, 118 (08) :2035-2043
[7]   Functional proteomics to dissect tyrosine kinase signalling pathways in cancer [J].
Kolch, Walter ;
Pitt, Andrew .
NATURE REVIEWS CANCER, 2010, 10 (09) :618-629
[8]   Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics [J].
Pan, Cuiping ;
Olsen, Jesper V. ;
Daub, Henrik ;
Mann, Matthias .
MOLECULAR & CELLULAR PROTEOMICS, 2009, 8 (12) :2796-2808
[9]   Specificity in signal transduction: From phosphotyrosine-SH2 domain interactions to complex cellular systems [J].
Pawson, T .
CELL, 2004, 116 (02) :191-203
[10]   BCR-ABL-INDUCED ONCOGENESIS IS MEDIATED BY DIRECT INTERACTION WITH THE SH2 DOMAIN OF THE GRB-2 ADAPTER PROTEIN [J].
PENDERGAST, AM ;
QUILLIAM, LA ;
CRIPE, LD ;
BASSING, CH ;
DAI, ZH ;
LI, NX ;
BATZER, A ;
RABUN, KM ;
DER, CJ ;
SCHLESSINGER, J ;
GISHIZKY, ML .
CELL, 1993, 75 (01) :175-185